chr2-88627211-CCAGCAGCAG-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_004836.7(EIF2AK3):βc.55_63delβ(p.Leu19_Leu21del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000025 in 1,278,450 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β ).
Frequency
Genomes: π 0.0 ( 0 hom., cov: 0)
Exomes π: 0.000025 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
EIF2AK3
NM_004836.7 inframe_deletion
NM_004836.7 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.66
Genes affected
EIF2AK3 (HGNC:3255): (eukaryotic translation initiation factor 2 alpha kinase 3) The protein encoded by this gene phosphorylates the alpha subunit of eukaryotic translation-initiation factor 2, leading to its inactivation, and thus to a rapid reduction of translational initiation and repression of global protein synthesis. This protein is thought to modulate mitochondrial function. It is a type I membrane protein located in the endoplasmic reticulum (ER), where it is induced by ER stress caused by malfolded proteins. Mutations in this gene are associated with Wolcott-Rallison syndrome. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.000025 (32/1278450) while in subpopulation AMR AF= 0.000156 (4/25570). AF 95% confidence interval is 0.0000534. There are 0 homozygotes in gnomad4_exome. There are 17 alleles in male gnomad4_exome subpopulation. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EIF2AK3 | NM_004836.7 | c.55_63del | p.Leu19_Leu21del | inframe_deletion | 1/17 | ENST00000303236.9 | NP_004827.4 | |
EIF2AK3 | XM_047446430.1 | c.55_63del | p.Leu19_Leu21del | inframe_deletion | 1/12 | XP_047302386.1 | ||
EIF2AK3 | XM_047446428.1 | c.17+469_17+477del | intron_variant | XP_047302384.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EIF2AK3 | ENST00000303236.9 | c.55_63del | p.Leu19_Leu21del | inframe_deletion | 1/17 | 1 | NM_004836.7 | ENSP00000307235 | P1 | |
EIF2AK3 | ENST00000682892.1 | c.-145-13367_-145-13359del | intron_variant | ENSP00000507214 | ||||||
EIF2AK3 | ENST00000652099.1 | c.53_61del | p.Leu19_Leu21del | inframe_deletion, NMD_transcript_variant | 1/18 | ENSP00000498211 | ||||
EIF2AK3 | ENST00000652423.1 | c.55_63del | p.Leu19_Leu21del | inframe_deletion, NMD_transcript_variant | 1/4 | ENSP00000498948 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 151044Hom.: 0 Cov.: 0 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
151044
Hom.:
Cov.:
0
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000460 AC: 3AN: 65220Hom.: 0 AF XY: 0.0000804 AC XY: 3AN XY: 37308
GnomAD3 exomes
AF:
AC:
3
AN:
65220
Hom.:
AF XY:
AC XY:
3
AN XY:
37308
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000250 AC: 32AN: 1278450Hom.: 0 AF XY: 0.0000270 AC XY: 17AN XY: 629790
GnomAD4 exome
AF:
AC:
32
AN:
1278450
Hom.:
AF XY:
AC XY:
17
AN XY:
629790
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 151044Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 73738
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
151044
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
73738
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 12, 2023 | This variant, c.55_63del, results in the deletion of 3 amino acid(s) of the EIF2AK3 protein (p.Leu19_Leu21del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with EIF2AK3-related conditions. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at